American biotech Nucleus RadioPharma has raised $56m in Series A funding, led by GE HealthCare and Eclipse, to enhance accessibility of radiopharmaceuticals. The funds will also contribute to establishing manufacturing facilities around the US and improve the development and commercialisation of its radiopharmaceuticals. The radiopharmaceutical market is tipped to grow from $4.5bn in 2022 to more than double in the next ten years, thanks to increasing interest and investment.
AI Website Generators Repurposed by Adversaries for Malware Campaigns – GBHackers News
AI Website Generators Repurposed by Adversaries for Malware Campaigns GBHackers News
